Duopharma Biotech Bhd
KLSE:DPHARMA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.13
1.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Duopharma Biotech Bhd
Cash from Operating Activities
Duopharma Biotech Bhd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Cash from Operating Activities
myr52.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
6%
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Cash from Operating Activities
myr11m
|
CAGR 3-Years
20%
|
CAGR 5-Years
4%
|
CAGR 10-Years
20%
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Cash from Operating Activities
myr46.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Cash from Operating Activities
myr26.9m
|
CAGR 3-Years
4%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Cash from Operating Activities
myr42.9m
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Cash from Operating Activities
myr61.5m
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
See Also
What is Duopharma Biotech Bhd's Cash from Operating Activities?
Cash from Operating Activities
52.5m
MYR
Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Cash from Operating Activities amounts to 52.5m MYR.
What is Duopharma Biotech Bhd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
6%
Over the last year, the Cash from Operating Activities growth was 60%. The average annual Cash from Operating Activities growth rates for Duopharma Biotech Bhd have been -3% over the past three years , -9% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
